Investigators from the United Kingdom have discovered drugs that could reduce the chances of death by Covid-19, which has increased the number of millions of lives worldwide, of which more than 88,500 are registered in the referendum.
According to a BBC News article, anti-inflammatory drugs “that save a life for every 12 people who receive the treatment”.
The medicines, administered by goteo, son tocilizumab and sarilumab, the pills are summed up in the favorable effects that are given with a steroid drug called dexamethasone.
The investigation was carried out by investigators who carried out a test in the intensive care units of the National Health Service of the United Kingdom (NHS).
“Treatments accelerate the recovery of patients and reduce approximately once a week the patients in critical condition should pass intensive care”, continues the BBC article, written by Michelle Roberts, Editor-in-Chief.
At the price of the elevated price (between US $ 1,000 and US $ 1,350 per patient), experts say that the value is less than the cost of an intensive care unit, of around US $ 2,700.
“For every 12 patients treated with these drugs, I hope to save a life. It has a great effect,” said Professor Anthony Gordon, investigating officer at the Imperial College London in the BBC.
Pharmacological referrals reduce inflammation, which can accelerate in patients with obesity-19 and cause death in the pulses and other organs.
Results
According to the REMAP-CAP study carried out in six different countries, including the United Kingdom, 36% of patients with covet-19 intensive care recipients receive increased mortality.
While the number is reduced by one quarter to sum up the new medicines within the 24 posterior hours of intensive care patients.
From his side, the Secretary of Health for Social Attainment of the United Kingdom, Matt Hancock, and Professor Stephen Powis, National Medical Director of the NHS, will present the hallazgo and consider this hecho as another positive step forward in continuing the virus.
Recommendation
The experts are recommending the medicines that the administering to any coronavirus patient whose condition is deteriorating, need to receive dexamethasone, and need intensive care.
As far as tocilizumab, sarilumab is concerned, the United Kingdom governs the list of products with which exports are restricted.
Michelle Roberts, editor-in-chief of BBC News’s article, has been reviewing this research for some time now and has revised it by other experts who have published it in a medical journal, said.